Author Bandelow, Borwin
-
2000 | Conference Abstract
Responsiveness of central serotonin receptors in panic disorder: Effects of clomipramine treatment and exercise
Broocks, A.; Ruther, E.; Munzel, U.; Hajak, G.; Wedekind, D. & Bandelow, B. (2000)
European Psychiatry, 15
Paris cedex 15: Editions Scientifiques Medicales Elsevier. DOI: https://doi.org/10.1016/S0924-9338(00)94044-6
Details DOI WoS
-
2000 | Journal Article
Salivary, total plasma and plasma free cortisol in panic disorder
Wedekind, D.; Bandelow, B.; Broocks, A.; Hajak, G. & Ruther, E. (2000)
Journal of Neural Transmission, 107(7) pp. 831-837. DOI: https://doi.org/10.1007/s007020070062
Details DOI PMID PMC WoS
-
2000 | Journal Article
Plasma homocysteine is a predictor of alcohol withdrawal seizures
Bleich, S.; Degner, D.; Bandelow, B.; von Ahsen, N.; Ruther, E. & Kornhuber, J. (2000)
Neuroreport, 11(12) pp. 2749-2752. DOI: https://doi.org/10.1097/00001756-200008210-00028
Details DOI PMID PMC WoS
-
2000 | Journal Article
Diurnal variation of cortisol in panic disorder
Bandelow, B.; Wedekind, D.; Sandvoss, V.; Broocks, A.; Hajak, G.; Pauls, J. & Peter, H. et al. (2000)
Psychiatry Research, 95(3) pp. 245-250. DOI: https://doi.org/10.1016/S0165-1781(00)00183-9
Details DOI PMID PMC WoS
-
2000 | Journal Article
Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder
Pauls, J.; Bandelow, B.; Ruther, E. & Kornhuber, J. (2000)
Journal of Neural Transmission, 107(11) pp. 1361-1366. DOI: https://doi.org/10.1007/s007020070023
Details DOI PMID PMC WoS
-
2000 | Journal Article
Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder
Broocks, A.; Bandelow, B.; George, A.; Jestrabeck, C.; Opitz, M.; Bartmann, U. & Gleiter, C. H. et al. (2000)
International Clinical Psychopharmacology, 15(3) pp. 153-161. DOI: https://doi.org/10.1097/00004850-200015030-00004
Details DOI PMID PMC WoS
-
2000 | Journal Article
The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial
Bandelow, B.; Broocks, A.; Pekrun, G.; George, A.; Meyer, T.; Pralle, L. & Bartmann, U. et al. (2000)
Pharmacopsychiatry, 33(5) pp. 174-181. DOI: https://doi.org/10.1055/s-2000-12982
Details DOI PMID PMC WoS
-
2000 | Journal Article | Letter Note
Myocarditis associated with clozapine treatment
Degner, D.; Bleich, S.; Grohmann, R.; Bandelow, B. & Ruther, E. (2000)
Australian and New Zealand Journal of Psychiatry, 34(5). DOI: https://doi.org/10.1080/j.1440-1614.2000.0822n.x
Details DOI PMID PMC WoS
-
2000 | Journal Article
Advances in the pharmacotherapy of depression by new antidepressants
Broocks, A.; Junghanns, K.; Thiel, A.; Gleiter, C. H. & Bandelow, B. (2000)
Fortschritte der Neurologie · Psychiatrie, 68(1) pp. 17-24. DOI: https://doi.org/10.1055/s-2000-11639
Details DOI PMID PMC WoS
-
2000 | Journal Article
Confusion and excitability of initially undetermined cause in the course of poisoning with deadly nightshade in attempted suicide: symptoms, differential diagnosis, toxicology and physostigmine treatment of an anticholinergic syndrome
Heindl, S.; Binder, C.; Desel, H.; Matthies, U.; Lojewski, I.; Bandelow, B. & Kahl, G. F. et al. (2000)
DMW - Deutsche Medizinische Wochenschrift, 125(45) pp. 1361-1365. DOI: https://doi.org/10.1055/s-2000-8178
Details DOI PMID PMC WoS
-
2001 | Journal Article
Generalized anxiety disorders - A neglected illness? Background and aims of the GAD-P-Study
Wittchen, H.-U.; Linden, M.; Schwarzer, W.; Riemann, D.; Boerner, R. J. & Bandelow, B. (2001)
MMW-FORTSCHRITTE DER MEDIZIN, pp. 1-4.
Details WoS
-
2001 | Conference Abstract
Increased psychobehavioral responsiveness to M-chlorophenylpiperazine (m-CPP) and ipsapirone (IPS) in patients with panic disorder (PDA)
Broocks, A.; Bandelow, B.; George, A. & Roed, I. S. (2001)
Journal of Neurochemistry, 78
Oxford: Blackwell Science Ltd.
Details WoS
-
2001 | Journal Article
Separation anxiety and actual separation experiences during childhood in patients with panic disorder
Bandelow, B.; Tichauer, G. A.; Spath, C.; Broocks, A.; Hajak, G.; Bleich, S. & Ruther, E. (2001)
The Canadian Journal of Psychiatry, 46(10) pp. 948-952.
Details PMID PMC WoS
-
2001 | Journal Article
Cortisol in night-urine: Introduction of a research method in psychoneuroendocrinology
Doering, S.; Wedekind, D.; Pilz, J.; Bandelow, B.; Adler, L. & Huether, G. (2001)
ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 47(1) pp. 42-57.
Details PMID PMC WoS
-
2001 | Journal Article
Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects
Broocks, A.; Meyer, T.; Gleiter, C. H.; Hillmer-Vogel, U.; George, A.; Bartmann, U. & Bandelow, B. (2001)
Psychopharmacology, 155(3) pp. 234-241. DOI: https://doi.org/10.1007/s002130100706
Details DOI PMID PMC WoS
-
2002 | Conference Abstract
How long to treat anxiety disorders?
Bandelow, B. (2002)
European Neuropsychopharmacology, 12 pp. S159-S160.
Amsterdam: Elsevier Science Bv.
Details WoS
-
2002 | Conference Abstract
Sertraline versus paroxetine in the treatment of panic disorder: A multinational randomized double-blind 15 week study
Bandelow, B.; Behnke, K.; Lenoir, S.; Hendriks, G. J.; Alkin, T.; Dombrowski, A. & Goebel, C. (2002)
European Neuropsychopharmacology, 12
Amsterdam: Elsevier Science Bv.
Details WoS
-
2002 | Conference Abstract
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder
Broocks, A.; Hajak, G.; Bandelow, B.; Koch, K.; Schweiger, U. & Hohagen, F. (2002)
European Psychiatry, 17
Paris cedex 15: Editions Scientifiques Medicales Elsevier.
Details WoS